Sotera Health Analyst Ratings
RBC Capital Reiterates Outperform on Sotera Health, Maintains $17 Price Target
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $17
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $17
Sotera Health (SHC.US) was first covered by Piper Sandler, which gave it a neutral rating, with a target price of $13.00.
Sotera Health Analyst Ratings
Barclays: Maintaining the Sotera Health (SHC.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $19.00 to $14.00.
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings
Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18
Sotera Health Analyst Ratings
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target Is $15.50
Sotera Health Analyst Ratings
Sotera Health (SHC) Receives a Buy From RBC Capital
Sotera Health Analyst Ratings
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings
Sotera Health Analyst Ratings